This device is intended for use in real-time monitoring of routine patient status and alarm events on medical devices. It serves as a parallel, redundant mechanism to inform the clinical staff of patient events. It is intended to be a secondary means of annunciating and displaying patient alarm information to mobile healthcare providers.

AlarmView is limited to use by qualified medical professionals who have been trained on the use of the device. It is intended for use in hospital and hospital type environments and is not for home use.

AlarmView is intended to supplement and not to replace any part of the current device monitoring procedures.

AlamView is not considered in and of itself to be diagnostic without skilled interpretation and does not replace physician's care.

AlarmView is currently validated for use with the N-x9y and N-3x00 data protocols.

Device Description

AlarmView™ is a paging system that interfaces with a primary patient clinical device in order to provide a secondary means of annunciating and displaying patient alarm information to mobile health care providers.

AlarmView reads the patient information from the output data port and does not change the primary monitor in any way. It formats the patient information into a message that can be transmitted to a pager carried by mobile health careqivers. AlarmView does not diagnose alarms.

AlarmView consists of the AV Transmitter, AV Pager, and the AC PDA (Personal Digital Assistant) used for administration.

AI/ML Overview

The provided document, K992848 Summary of Safety and Effectiveness for the AlarmView™ - Physiological Monitor System, Network and Communication, does not contain specific acceptance criteria or details of a study demonstrating the device meets such criteria.

The document primarily focuses on establishing substantial equivalence to predicate devices based on:

Intended Use: AlarmView™ is a paging system for real-time monitoring of patient status and alarm events, serving as a secondary means to inform mobile healthcare providers. It is intended to supplement existing monitoring, not replace it, and is for use by trained professionals in hospital environments.
Technological Characteristics: The document states that AlarmView™ has the same technological characteristics as its predicate devices, primarily consisting of a paging system connected to a medical device to transmit patient data.
Safety and Efficacy: It claims AlarmView™ has the same safety and efficacy characteristics as the predicate devices.

Key points from the document regarding the "study" aspect are:

The submission is a 510(k) for substantial equivalence to legally marketed predicate devices.
There is no mention of a clinical study, performance study, or any specific testing with acceptance criteria for the AlarmView™ system itself described in this summary.
The FDA approval letter from November 19, 1999, confirms the finding of substantial equivalence based on the provided information.
The device is "validated for use with the N-x9y and N-3x00 data protocols," which implies some level of technical testing, but specifics of this validation (e.g., methodology, results, acceptance criteria) are not detailed in this summary.

Therefore, based solely on the provided text, the requested information cannot be fully extracted for the AlarmView™ device as a new study with explicit acceptance criteria and performance data is not presented.

However, to address the prompt's request for format, if such a study existed and was described in this document, the information would be presented as follows (with "N/A" for details not found in the provided text):

1. Table of Acceptance Criteria and Reported Device Performance:

Acceptance Criteria (e.g., Latency, Message Delivery Rate, Error Rate)	Reported Device Performance
No specific acceptance criteria defined in the document.	No specific performance data reported in the document.
(Hypothetical: Message delivery time < 5 seconds for critical alarms)	(Hypothetical: All critical alarms delivered within 3 seconds)
(Hypothetical: Data integrity: 0% data corruption)	(Hypothetical: No data corruption observed)

2. Sample size used for the test set and the data provenance:

Sample size for test set: N/A (No specific test set or study described)
Data provenance: N/A (No study data provided)

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

Number of experts: N/A
Qualifications of experts: N/A

4. Adjudication method for the test set:

Adjudication method: N/A

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

MRMC study: No. The AlarmView™ system is a paging communication system, not an AI-assisted diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

Standalone performance: N/A (This device is a communication system, not an algorithm with standalone performance metrics in the typical sense of AI/diagnostic devices.) The document only states it "does not diagnose alarms" and does not replace physician's care.

7. The type of ground truth used:

Type of ground truth: N/A (No specific ground truth described as no performance study is detailed.) The device's function is to relay existing alarm information.

8. The sample size for the training set:

Sample size for training set: N/A (No training set described, as this is not an AI/learning algorithm device.)

9. How the ground truth for the training set was established:

Ground truth for training set: N/A

Summary

{0}------------------------------------------------

K992848

Summary of Safety and Effectiveness: Data Critical Corporation 510(k) Notification: AlarmView™ - Physiological Monitor System, Network and Communication August 23, 1999

510(k) SUMMARY:

SAFETY AND EFFECTIVENESS SUMMARY

This information of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

Submitter's Name/Address:

Drew D. Weaver Director of Regulatory Affairs Data Critical Corporation 19820 North Creek Parkway, #100 Bothell, WA 98011

(425) 482-7000 (425) 482-7010 facsimile

Contact Person:

Same as above

Date Summary Prepared:

August 23, 1999

Device Name:

Common Name:	Physiological Monitor System, Network andCommunication (Patient information Paging System)
Trade Name:	AlarmView™ System
Classification (if known):	Physiological Monitor System, Network andCommunication (21 CFR 870.2910)
	74 MSXClass II

{1}------------------------------------------------

Summary of Safety and Effectiveness: Data Critical Corporation 510(k) Notification: AlarmView™ - Physiological Monitor System, Network and Communication August 23, 1999

Predicate Devices:

AlarmView™ System is substantially equivalent to the following predicate devices:

StatView™ System by Data Critical Corporation 1)
TS2000 by Trincore Systems 2)
Pager-LAN by GE Marquette Medical Systems 3)
1. "Paging" by Vitalcom.

Applicant Device Description:

AlarmView consists of the AV Transmitter, AV Pager, and the AC PDA (Personal Digital Assistant) used for administration.

Applicant Device Intended Use:

AlarmView is intended to supplement and not to replace any part of the current device monitoring procedures.

AlarmView is not considered in and of itself to be diagnostic without skilled interpretation and does not replace physician's care.

{2}------------------------------------------------

Summary of Safety and Effectiveness: Data Critical Corporation 510(k) Notification: AlarmView™ - Physiological Monitor System, Network and Communication August 23, 1999

Technological Characteristics:

AlarmView is the same in technological characteristics as the cited predicate devices. Most of the predicate devices consist of a paging system. In all cases, the predicates are connected to a medical device that is used to transmit patient data to an appropriate health care provider.

AlarmView has the same safety and efficacy characteristics as the predicate devices.

{3}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure or a bird in flight, composed of three curved lines.

Public Health Service

NOV 1 9 1999

Mr. Drew D. Weaver Director of Regulatory Affairs Data Critical Corporation 19820 North Creek Parkway, #100 Bothell, WA 98011

Re : K992848 Alarmview System II (Two) Regulatory Class: Product Code: MSX Dated: August 23, 1999 Received: August 24, 1999

Dear Mr. Weaver:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to A substantially equivalent determination assumes compliance with 895. the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply In addition, with the GMP requlation may result in requlatory action. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

{4}------------------------------------------------

Page 2 - Mr. Drew D. Weaver

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a leqally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours

KeKe Hill

Celia M. Witten, Ph.D., M.D. Acting Director Division of Cardiovascular, Respiratory and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

K992848

INDICATIONS FOR USE STATEMENT

Indications For Use:

AlarmView is intended to supplement and not to replace any part of the current device monitoring procedures.

AlamView is not considered in and of itself to be diagnostic without skilled interpretation and does not replace physician's care.

AlarmView is currently validated for use with the N-x9y and N-3x00 data protocols.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Cardiovascular, Respiratory,
and Neurological Devices
510(k) Number K992848

Prescription Use OR Over-The-Counter

Prescription Use (Per 21 CFR 801.109) OR

Over-The-Counter Use -------

(Optional Format 1-2-96)

Regulation Number and Section

§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).

(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).